Reward-related decision-making deficits and elevated impulsivity among MDMA and other drug users.

BACKGROUND The recreational drug, 3,4-methylenedioxymethamphetamine (MDMA; 'Ecstasy'), is a synthetic amphetamine derivative and a serotonin neurotoxin. MDMA use is associated with cognitive dysfunction and impulsivity, but since polydrug abuse is common among users it is difficult to attribute these problems specifically to MDMA. Moreover, few studies have examined reward-related cognitive processes. Our aim was to examine reward-related decision-making and impulsivity among MDMA users while controlling for polydrug use via appropriate comparison groups. METHODS We examined decision-making [Iowa Gambling Task, IGT; Bechara, A., Damasio, A.R., Damasio, H., Anderson, S.W., 1994. Insensitivity to future consequences following damage to human prefrontal cortex. Cognition 50, 7-15], self-reported impulsivity (Multidimensional Personality Questionnaire-Brief Form [constraint subscale]; Barratt Impulsiveness Scale; Zuckerman Sensation Seeking Scale), and drug use among 22 abstinent MDMA users, 30 other drug users, and 29 healthy non-drug controls. RESULTS MDMA and other drug users showed comparable patterns of decision-making and impulsivity. However, both drug groups demonstrated poorer IGT performance and elevated self-reported impulsivity relative to controls. Poorer decision-making was related to heavier drug use in the past year, heavier weekly alcohol use, and meeting lifetime substance use disorder (SUD) criteria for more drug classes. Elevated impulsivity was associated with heavier drug use, heavier weekly alcohol use, more lifetime SUDs, and higher self-reported depression levels. CONCLUSIONS These findings contradict the idea that MDMA is specifically associated with deficient decision-making. Drug users, in general, may be at risk for decision-making deficits and elevated impulsivity. Such behaviors may represent trait factors that lead to the initiation of drug and alcohol use, and/or they may represent behavior patterns that are exacerbated by extensive use.

[1]  E. D. De Souza,et al.  3,4-Methylenedioxymethamphetamine and 3,4-methylenedioxyamphetamine destroy serotonin terminals in rat brain: quantification of neurodegeneration by measurement of [3H]paroxetine-labeled serotonin uptake sites. , 1987, The Journal of pharmacology and experimental therapeutics.

[2]  David S. Leland,et al.  Increased risk-taking decision-making but not altered response to punishment in stimulant-using young adults. , 2005, Drug and alcohol dependence.

[3]  M. Morgan.  Recreational Use of “Ecstasy” (MDMA) Is Associated with Elevated Impulsivity , 1998, Neuropsychopharmacology.

[4]  Visuospatial memory impairments in users of MDMA (‘ecstasy’) , 2004, Psychopharmacology.

[5]  E. Gouzoulis-Mayfrank,et al.  Psychological profile of abstinent recreational Ecstasy (MDMA) users and significance of concomitant cannabis use , 2001, Human psychopharmacology.

[6]  E. Barratt.  Impulsiveness and aggression. , 1994 .

[7]  Jörg Daumann,et al.  High Intensity Dependence of Auditory Evoked Dipole Source Activity Indicates Decreased Serotonergic Activity in Abstinent Ecstasy (MDMA) Users , 2000, Neuropsychopharmacology.

[8]  K. Petersen,et al.  Mood, cognition and serotonin transporter availability in current and former ecstasy (MDMA) users , 2003, Psychopharmacology.

[9]  J. V. van Gerven,et al.  Cognitive performance and serotonergic function in users of ecstasy , 2000, Psychopharmacology.

[10]  Katharine Blick Hoyenga,et al.  Psychobiology: The Neuron and Behavior , 1987 .

[11]  W. Bickel,et al.  Shortened time horizons and insensitivity to future consequences in heroin addicts. , 1998, Addiction.

[12]  K. Boone,et al.  Neuropsychological Effects of 3,4-Methylenedioxymethamphetamine (MDMA or Ecstasy) in Recreational Users , 2003, The Clinical neuropsychologist.

[13]  Carlo Contoreggi,et al.  Drug abusers show impaired performance in a laboratory test of decision making , 2000, Neuropsychologia.

[14]  A. Beck,et al.  An inventory for measuring depression. , 1961, Archives of general psychiatry.

[15]  J. Ramaekers,et al.  Acute Effects of 3,4-Methylenedioxymethamphetamine (MDMA) on Behavioral Measures of Impulsivity: Alone and in Combination with Alcohol , 2006, Neuropsychopharmacology.

[16]  L. Reneman,et al.  The Acute and Chronic Effects of MDMA (“Ecstasy”) on Cortical 5-HT2A Receptors in Rat and Human Brain , 2002, Neuropsychopharmacology.

[17]  F. Schifano,et al.  Personality dimensions and psychopathological profiles of Ecstasy users , 2001, Human psychopharmacology.

[18]  F. Vollenweider,et al.  Psychological and Cardiovascular Effects and Short-Term Sequelae of MDMA (“Ecstasy”) in MDMA-Naïve Healthy Volunteers , 1998, Neuropsychopharmacology.

[19]  J E Steinmetz,et al.  Decision-making biases, antisocial personality, and early-onset alcoholism. , 2000, Alcoholism, clinical and experimental research.

[20]  J. Sattler.  Assessment of Children: Cognitive Applications , 2001 .

[21]  R. Dafters,et al.  Contribution of cannabis and MDMA ("ecstasy") to cognitive changes in long-term polydrug users , 2004, Psychopharmacology.

[22]  H. Curran,et al.  Is MDMA (‘Ecstasy’) Neurotoxic in Humans? An Overview of Evidence and of Methodological Problems in Research , 2000, Neuropsychobiology.

[23]  A. Damasio.  Descartes' error: emotion, reason, and the human brain. avon books , 1994 .

[24]  V. Curran,et al.  Sub-acute effects of MDMA (±3,4-methylenedioxymethamphetamine, "ecstasy") on mood: evidence of gender differences , 2002, Psychopharmacology.

[25]  J. Krystal,et al.  Chronic 3,4-methylenedioxymethamphetamine (MDMA) use: effects on mood and neuropsychological function? , 1992, The American journal of drug and alcohol abuse.

[26]  J. M. Cattell,et al.  The Psychological Corporation , 1923, Science.

[27]  H. Damasio,et al.  Dissociation Of Working Memory from Decision Making within the Human Prefrontal Cortex , 1998, The Journal of Neuroscience.

[28]  John Monahan,et al.  Violence and mental disorder: Developments in risk assessment. , 1994 .

[29]  M. Zuckerman.  Sensation Seeking : Beyond the Optimal Level of Arousal , 1979 .

[30]  B. Sahakian,et al.  The effect of polymorphism at the serotonin transporter gene on decision-making, memory and executive function in ecstasy users and controls , 2006, Psychopharmacology.

[31]  B. Sahakian,et al.  Neuropsychological evidence of a relatively selective profile of temporal dysfunction in drug-free MDMA ("ecstasy") polydrug users , 2002, Psychopharmacology.

[32]  E. Gouzoulis-Mayfrank,et al.  Impaired cognitive performance in drug free users of recreational ecstasy (MDMA) , 2000, Journal of neurology, neurosurgery, and psychiatry.

[33]  M. Morgan,et al.  Ecstasy (MDMA): a review of its possible persistent psychological effects , 2000, Psychopharmacology.

[34]  A. Parrott,et al.  Ecstasy use: cognitive deficits related to dosage rather than self-reported problematic use of the drug , 2001, Journal of psychopharmacology.

[35]  F. Schifano,et al.  MDMA ('ecstasy') consumption in the context of polydrug abuse: a report on 150 patients. , 1998, Drug and alcohol dependence.

[36]  M. Luciana,et al.  Neurocognitive function in users of MDMA: the importance of clinically significant patterns of use , 2004, Psychological Medicine.

[37]  E. Gouzoulis-Mayfrank,et al.  Memory impairment suggests hippocampal dysfunction in abstinent ecstasy users , 2003, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[38]  A. Damasio.  Descartes’ Error. Emotion, Reason and the Human Brain. New York (Grosset/Putnam) 1994. , 1994 .

[39]  J. Robinson,et al.  Ecstasy (MDMA): are the psychological problems associated with its use reversed by prolonged abstinence? , 2001, Psychopharmacology.

[40]  Philip C. Kendall,et al.  Issues and recommendations regarding use of the Beck Depression Inventory , 1987, Cognitive Therapy and Research.

[41]  S. Gardini,et al.  Effects of (±) 3,4-methylene–dioxymethamphetamine (ecstasy) on dopamine system function in humans , 2002, Behavioural Brain Research.

[42]  J. Powell,et al.  Recreational use of 3,4-methylenedioxymethamphetamine (MDMA) or ‘ecstasy’: evidence for cognitive impairment , 2001, Psychological Medicine.

[43]  Andrew C. Parrott,et al.  Ecstasy (MDMA) in Recreational Users: Self‐Reported Psychological and Physiological Effects , 1997 .

[44]  E. Gouzoulis-Mayfrank,et al.  Self-reported psychopathological symptoms in recreational ecstasy (MDMA) users are mainly associated with regular cannabis use: further evidence from a combined cross-sectional/longitudinal investigation , 2004, Psychopharmacology.

[45]  U. McCann,et al.  Memory impairment in abstinent MDMA ("Ecstasy") users , 1998, Neurology.

[46]  H. Curran,et al.  Altered response to tryptophan supplementation after long-term abstention from MDMA (ecstasy) is highly correlated with human memory function , 2003, Psychopharmacology.

[47]  M. Pérez-García,et al.  Strategic self-regulation, decision-making and emotion processing in poly-substance abusers in their first year of abstinence. , 2007, Drug and alcohol dependence.

[48]  M. Morgan.  Memory deficits associated with recreational use of “ecstasy” (MDMA) , 1999, Psychopharmacology.

[49]  R. Elliott,et al.  Dissociable functions in the medial and lateral orbitofrontal cortex: evidence from human neuroimaging studies. , 2000, Cerebral cortex.

[50]  Rodney J. Croft,et al.  The relative contributions of ecstasy and cannabis to cognitive impairment , 2001, Psychopharmacology.

[51]  R. Rogers,et al.  Elevated Impulsivity and Impaired Decision-Making in Abstinent Ecstasy (MDMA) Users Compared to Polydrug and Drug-Naïve Controls , 2006, Neuropsychopharmacology.

[52]  G. Gerra,et al.  Serotonergic function after (±)3,4‐methylene-dioxymethamphetarnine (‘Ecstasy’) in humans , 1998, International clinical psychopharmacology.

[53]  F. Vollenweider,et al.  No Difference in Brain Activation During Cognitive Performance Between Ecstasy (3,4-Methylenedioxymethamphetamine) Users and Control Subjects: A [H215O]-Positron Emission Tomography Study , 2001, Journal of clinical psychopharmacology.

[54]  F. Schifano.  Potential Human Neurotoxicity of MDMA (‘Ecstasy’): Subjective Self-Reports, Evidence from an Italian Drug Addiction Centre and Clinical Case Studies , 2000, Neuropsychobiology.

[55]  F. Vollenweider,et al.  Gender differences in the subjective effects of MDMA , 2001, Psychopharmacology.

[56]  A. Damasio,et al.  Insensitivity to future consequences following damage to human prefrontal cortex , 1994, Cognition.

[57]  T. Robbins,et al.  Dissociable Deficits in the Decision-Making Cognition of Chronic Amphetamine Abusers, Opiate Abusers, Patients with Focal Damage to Prefrontal Cortex, and Tryptophan-Depleted Normal Volunteers: Evidence for Monoaminergic Mechanisms , 1999, Neuropsychopharmacology.

[58]  K. Sher,et al.  Decision making and binge drinking: a longitudinal study. , 2007, Alcoholism, clinical and experimental research.

[59]  R. Rogers,et al.  Risk-taking on tests sensitive to ventromedial prefrontal cortex dysfunction predicts early relapse in alcohol dependency: a pilot study. , 2005, The Journal of neuropsychiatry and clinical neurosciences.

[60]  G. Bartzokis,et al.  Abstinence from Cocaine Reduces High-Risk Responses on a Gambling Task , 2000, Neuropsychopharmacology.

[61]  Catalina J. Hooper,et al.  Adolescents' performance on the Iowa Gambling Task: implications for the development of decision making and ventromedial prefrontal cortex. , 2004, Developmental psychology.

[62]  A. Lees,et al.  Cognitive performance in recreational users of MDMA or 'ecstasy': evidence for memory deficits , 1998, Journal of psychopharmacology.

[63]  A. Damasio,et al.  Emotion, decision making and the orbitofrontal cortex. , 2000, Cerebral cortex.

[64]  Patrick J. O'Donnell,et al.  Level of use of 3,4-methylenedioxymethamphetamine (MDMA or Ecstasy) in humans correlates with EEG power and coherence , 1999, Psychopharmacology.

[65]  T. Heffernan,et al.  Prospective memory, everyday cognitive failure and central executive function in recreational users of Ecstasy , 2001, Human psychopharmacology.

[66]  U. McCann,et al.  Cognitive performance in (±) 3,4-methylenedioxymethamphetamine (MDMA, “ecstasy”) users: a controlled study , 1999, Psychopharmacology.

[67]  J. Evenden.  Varieties of impulsivity , 1999, Psychopharmacology.

[68]  Jerome R Busemeyer,et al.  Psychological processes underlying risky decisions in drug abusers. , 2005, Psychology of addictive behaviors : journal of the Society of Psychologists in Addictive Behaviors.

[69]  F. Vollenweider,et al.  MDMA affects both error-rate dependent and independent aspects of decision-making in a two-choice prediction task , 2005, Journal of psychopharmacology.

[70]  A. Parrott,et al.  Psychobiological problems in heavy 'ecstasy' (MDMA) polydrug users. , 2000, Drug and alcohol dependence.

[71]  A. Bechara,et al.  Decision-making and addiction (part II): myopia for the future or hypersensitivity to reward? , 2002, Neuropsychologia.

[72]  G K L Butler,et al.  Impulsivity, risk taking and recreational 'ecstasy' (MDMA) use. , 2004, Drug and alcohol dependence.

[73]  H. Damasio,et al.  Characterization of the decision-making deficit of patients with ventromedial prefrontal cortex lesions. , 2000, Brain : a journal of neurology.

[74]  Monique Ernst,et al.  Decision making in adolescents with behavior disorders and adults with substance abuse. , 2003, The American journal of psychiatry.

[75]  A. Bechara,et al.  Cognitive function and mood in MDMA/THC users, THC users and non-drug using controls , 2006, Journal of psychopharmacology.

[76]  F. Moeller,et al.  Impulsivity and history of drug dependence. , 1998, Drug and alcohol dependence.

[77]  G. Gerra,et al.  Long-lasting effects of (±)3,4-methylene-dioxymethamphetamine (Ecstasy) on serotonin system function in humans , 2000, Biological Psychiatry.

[78]  Christopher J Patrick,et al.  Development and validation of a brief form of the Multidimensional Personality Questionnaire. , 2002, Psychological assessment.

[79]  Hanna Damasio,et al.  Decision-making and addiction (part I): impaired activation of somatic states in substance dependent individuals when pondering decisions with negative future consequences , 2002, Neuropsychologia.

[80]  Klaus P. Ebmeier,et al.  Reduced in vivo binding to the serotonin transporter in the cerebral cortex of MDMA (‘ecstasy’) users , 1999, British Journal of Psychiatry.

[81]  L S Seiden,et al.  Biochemical and histological evidence that methylenedioxymethylamphetamine (MDMA) is toxic to neurons in the rat brain. , 1987, The Journal of pharmacology and experimental therapeutics.

[82]  W. Overman,et al.  Performance on the IOWA card task by adolescents and adults , 2004, Neuropsychologia.

[83]  M. Stitzer,et al.  Methods for enhancing transition of substance dependent patients from inpatient to outpatient treatment. , 2001, Drug and alcohol dependence.

[84]  J. Rodgers,et al.  Cognitive performance amongst recreational users of "ecstasy , 2000, Psychopharmacology.

[85]  D. Yurgelun-Todd,et al.  Residual neuropsychological effects of illicit 3,4-methylenedioxymethamphetamine (MDMA) in individuals with minimal exposure to other drugs. , 2004, Drug and alcohol dependence.

[86]  W. Maier,et al.  Elevated impulsivity and impaired decision-making cognition in heavy users of MDMA (“Ecstasy”) , 2006, Psychopharmacology.

[87]  G. Ricaurte,et al.  Altered Serotonin Innervation Patterns in the Forebrain of Monkeys Treated with (±)3,4-Methylenedioxymethamphetamine Seven Years Previously: Factors Influencing Abnormal Recovery , 1999, The Journal of Neuroscience.

[88]  K I Bolla,et al.  Dose-related neurocognitive effects of marijuana use , 2002, Neurology.

[89]  S. Mitchell,et al.  Measures of impulsivity in cigarette smokers and non-smokers , 1999, Psychopharmacology.

[90]  J. Sattler.  Assessment of children: Cognitive applications, 4th ed. , 2001 .

[91]  N. Petry,et al.  Substance abuse, pathological gambling, and impulsiveness. , 2001, Drug and alcohol dependence.

[92]  Steven W Anderson,et al.  Decision-making deficits, linked to a dysfunctional ventromedial prefrontal cortex, revealed in alcohol and stimulant abusers , 2001, Neuropsychologia.

[93]  K. Merikangas,et al.  Personality, drug of choice, and comorbid psychopathology among substance abusers. , 2002, Drug and alcohol dependence.

[94]  G. Battaglia,et al.  Methylenedioxyamphetamine (MDA) and methylenedioxymethamphetamine (MDMA) cause selective ablation of serotonergic axon terminals in forebrain: immunocytochemical evidence for neurotoxicity , 1988, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[95]  R. Elliott,et al.  Ventromedial prefrontal cortex mediates guessing , 1999, Neuropsychologia.

[96]  J. Richards,et al.  Methylenedioxymethamphetamine-induced serotonin deficits are followed by partial recovery over a 52-week period. Part II: Radioligand binding and autoradiography studies. , 1996, The Journal of pharmacology and experimental therapeutics.

[97]  C. J. Schmidt,et al.  Neurotoxicity of the psychedelic amphetamine, methylenedioxymethamphetamine. , 1987, The Journal of pharmacology and experimental therapeutics.

[98]  Khader M Hasan,et al.  Diffusion Tensor Imaging in MDMA Users and Controls: Association with Decision Making , 2007, The American journal of drug and alcohol abuse.

[99]  J. Jonides,et al.  Storage and executive processes in the frontal lobes. , 1999, Science.